Neil Flash joins med comms group Lucid as chief commercial officerLucid Group has appointed Neil Flash to the newly-created role of chief commercial officer. He will also serve Share XNeil Flash joins med comms group Lucid as chief commercial officerhttps://pharmaphorum.com/news/lucid-group-neil-flash/
AstraZeneca commits to being carbon negative by 2030AstraZeneca has announced its ambition to have zero carbon emissions from its global operations by 2025 and to Share XAstraZeneca commits to being carbon negative by 2030https://pharmaphorum.com/news/astrazeneca-commits-to-being-carbon-negative-by-2030/
W2O acquires US advertising and med ed agency 21GRAMSW2O has bought US-based advertising and medical education 21GRAMS, expanding its direct-to-consumer, direct-to-provider and business-to-business advertising and marketing Share XW2O acquires US advertising and med ed agency 21GRAMShttps://pharmaphorum.com/news/w2o-advertising-med-ed-agency-21grams/
Syneos Health invests in Microsoft/Indegene platformBiopharma services company Syneos Health has taken a minority stake in Indegene Omnipresence, a partnership between life sciences Share XSyneos Health invests in Microsoft/Indegene platformhttps://pharmaphorum.com/news/syneos-health-microsoft-indegene-life-sciences-platform/
OPEN Health launches new Learning & Development specialist teamOPEN Health has launched a new specialist Learning & Development (L&D) team that will further expand its existing Share XOPEN Health launches new Learning & Development specialist teamhttps://pharmaphorum.com/sales-marketing/open-health-launches-new-learning-development-specialist-team/
Roche and Illumina forge genomics alliance for cancer testingRoche missed out on acquiring next-generation sequencing (NGS) specialist Illumina via a hostile takeover a few years back, Share XRoche and Illumina forge genomics alliance for cancer testinghttps://pharmaphorum.com/news/roche-and-illumina-forge-genomics-alliance-for-cancer-testing/
PharmaLex merges with CompliMedPharmaLex Group has completed its merger with CompliMed in the United Kingdom. CompliMed is the UK’s leading Healthcare Share XPharmaLex merges with CompliMedhttps://pharmaphorum.com/sales-marketing/pharmalex-merges-with-complimed/
FCB Health recruits Ross Quinn for new customer solutions roleRoss Quinn has joined the FCB Health Network to take up the newly-created role of director of customer Share XFCB Health recruits Ross Quinn for new customer solutions rolehttps://pharmaphorum.com/news/fcb-health-ross-quinn-julie-pilon/
Makara Health appoints Ekta Rohra as digital strategy directorUK-based international healthcare communications agency Makara Health has made a number of appointments to its team, including new Share XMakara Health appoints Ekta Rohra as digital strategy directorhttps://pharmaphorum.com/news/makara-health-ekta-rohra/
GSK completes travel vaccine offload as revamp continuesGlaxoSmithKline’s last act of 2019 was the completion of its near-€1 billion deal to divest two vaccines to Share XGSK completes travel vaccine offload as revamp continueshttps://pharmaphorum.com/news/gsk-completes-travel-vaccine-offload-as-revamp-continues/
Sumitomo, Roivant close $3 billion deal, forming SumitovantA new international biotech – Sumitovant Biopharma – has been created after Sumitomo Dainippon’s strategic alliance with Roivant Share XSumitomo, Roivant close $3 billion deal, forming Sumitovanthttps://pharmaphorum.com/news/sumitomo-roivant-close-3-billion-deal-forming-sumitovant/
EMA counts the cost of Brexit in lost staff and narrower workloadThe EMA’s forced move from London to Amsterdam in the wake of the UK’s decision to leave the Share XEMA counts the cost of Brexit in lost staff and narrower workloadhttps://pharmaphorum.com/news/ema-counts-the-cost-of-brexit-in-lost-staff-and-narrower-workload/
Envision Pharma Group appoints David Thompson as CEOScientific communications organisation the Envision Pharma Group has revamped its top team, promoting David Thompson to chief executive Share XEnvision Pharma Group appoints David Thompson as CEOhttps://pharmaphorum.com/news/envision-pharma-group-ceo-david-thompson/
As election year looms, Democrats lever drug pricing bill through HouseThe US House of Representatives passed a bill that will allow the federal government to negotiate drug prices, Share XAs election year looms, Democrats lever drug pricing bill through Househttps://pharmaphorum.com/news/as-election-year-looms-democrats-lever-drug-pricing-bill-through-house/
ABPI looks internally for new CEO, naming Richard TorbettThe new chief executive of the Association of the British Pharmaceutical Industry (ABPI) will be Dr Richard Torbett Share XABPI looks internally for new CEO, naming Richard Torbetthttps://pharmaphorum.com/news/abpi-looks-internally-for-new-ceo-naming-richard-torbett/
W2O acquisitions continue as it buys Radius Digital ScienceW2O has made its third acquisition in recent months, buying Radius Digital Science, a New Jersey-based scientific creative Share XW2O acquisitions continue as it buys Radius Digital Sciencehttps://pharmaphorum.com/news/w2o-radius-digital-science/
Mavenclad helps Merck shrug off Rebif decline in MSAccelerating sales of Merck KGaA’s oral multiple sclerosis therapy Mavenclad helped the company to a double-digit rise in Share XMavenclad helps Merck shrug off Rebif decline in MShttps://pharmaphorum.com/news/mavenclad-helps-merck-shrug-off-rebif-decline-in-ms/
Claire Gillis wins Women in Marketing health leadership prizeWPP’s health practice international CEO Claire Gillis picked up the inaugural healthcare marketing leadership prize at last night’s Share XClaire Gillis wins Women in Marketing health leadership prizehttps://pharmaphorum.com/news/claire-gillis-women-in-marketing-award/
